Bumetanide
- Generic Name
- Bumetanide
- Brand Names
- Bumex, Burinex
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20N2O5S
- CAS Number
- 28395-03-1
- Unique Ingredient Identifier
- 0Y2S3XUQ5H
- Background
Bumetanide is a sulfamyl diuretic.
- Indication
For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.
- Associated Conditions
- Edema
Lupin Receives FDA Approval for Generic Bumetanide Injection
• Lupin has secured FDA approval for its bumetanide injection, available in single and multiple-dose vials, offering a generic alternative to Validus Pharmaceuticals' Bumex.
• The bumetanide injection is indicated for treating edema linked to congestive heart failure, hepatic, and renal diseases, including nephrotic syndrome.
• Manufactured at Lupin's Nagpur facility in India, the generic bumetanide injection addresses a market valued at approximately $20 million, according to IQVIA data from July 2024.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath